(Q40534109)

21 September 2017

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes (English)

1 reference

Muralikrishna Gangadharan Komala

21 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Simon Gross

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Amgad Zaky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Carol Pollock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Usha Panchapakesan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

16 September 2015

1 reference

21 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

423-431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26375854%20AND%20SRC:MED&resulttype=core&format=json

Novel aspects of cellular action of dipeptidyl peptidase IV/CD26.

2 June 2020

cites work

1 reference

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

Peptidomics of the prolyl peptidases

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).

21 January 2018

1 reference

Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice

21 January 2018

1 reference

High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes

21 January 2018

1 reference